NephroPlus
PrivateLast Round
IPO Announced
Dec 10, 2025
Est. Valuation
$550.9M
Total Funding Raised
$210.24M
Company Overview
NephroPlus is a healthcare company that operates a network of dialysis centers providing high-quality and affordable dialysis services, along with treatments for kidney and urological issues through standardized protocols and continuous innovation.
Sector
Healthcare & Life Sciences
Verticals
Facility Management, Telemedicine
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NephroPlus Comps
Public and private peers based on sector, stage, and business model.
NephroPlus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Dec 10, 2025 | ||||
| Series F | May 3, 2024 | ||||
| Debt | Dec 19, 2022 | ||||
| Series E | Dec 13, 2021 | ||||
| Series D | Nov 25, 2019 | ||||
Series C | Aug 24, 2016 |
Key People
Founding team and executive leadership
NephroPlus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCP | Series E |
| Polar Capital | IPO |
| Prudential Assurance Company | IPO |
| DSP Mutual Fund | IPO |
| Investcorp | Series F, Series E, Series D |
| International Finance Corporation | Series D, IPO, Series C, Series F, Series B |
| Edoras Investment Holding | Series F |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Launched an AI-enabled monitoring platform for dialysis centers.
- Mar 18, 2026
Launched a mobile app in the Philippines to manage patient treatment.
NephroPlus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NephroPlus's valuation, stock price, and market status.
